Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2012
Accuracy of a GFR estimating equation over time in people with a wide range of kidney functionSmita Padala, Hocine Tighiouart, Lesley A Inker, et al.
Kidney Medicine|January 17, 2025
Renal Physiology Education via Podcast: Channel Your EnthusiasmMelanie P Hoenig, Anna R Gaddy, Priti Meena, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 26, 2006
Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic reviewDinna N Cruz, Mark A Perazella, Rinaldo Bellomo, et al.
Clinical Kidney Journal|May 8, 2023
The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysisMehmet Kanbay, Sidar Copur, Dimitrie Siriopol, et al.
Diabetes Care|July 28, 2004
Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal diseaseAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.
Kidney International. Supplement|December 23, 2004
Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuriaAndrew J Palmer, Lieven Annemans, Stéphane Roze, et al.
Practical Laboratory Medicine|April 25, 2022
Urine testing to differentiate glomerular from tubulointerstitial diseases on kidney biopsyAnna C Tran, Hannah Melchinger, Jason Weinstein, et al.
Clinical Therapeutics|August 30, 2003
The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathyRoger A Rodby, Chion Fang Chiou, Jeff Borenstein, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 29, 2011
Risk of poor outcomes with novel and traditional biomarkers at clinical AKI diagnosisIsaac E Hall, Steven G Coca, Mark A Perazella, et al.
International Urology and Nephrology|October 25, 2022
Immune checkpoints inhibitors and its link to acute kidney injury and renal prognosisMehmet Kanbay, Abdullah Burak Yildiz, Dimitrie Siriopol, et al.
Pageof 22